What is the optimal number of embryos to transfer for POSEIDON group 1 and group 2? A retrospective study
- PMID: 38822354
- PMCID: PMC11140960
- DOI: 10.1186/s13048-024-01443-y
What is the optimal number of embryos to transfer for POSEIDON group 1 and group 2? A retrospective study
Abstract
Background: The 2016 Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria redefined the poor responders as low prognosis patients. The embryo transfer strategy for POSEIDON patients remained to be addressed. This study aimed to investigate the optimized number of embryos to transfer for unexpected low-prognosis patients (POSEIDON Group 1 and Group 2) with blastocyst transfer in their first frozen cycle.
Methods: A retrospective cohort study of 2970 patients who underwent frozen-thawed embryo transfer (FET) between January 2018 and December 2021. Patients from POSEIDON Group 1 (N = 219) and Group 2 (N = 135) who underwent blastocyst transfer in their first FET cycles were included and divided into the elective single embryo transfer (eSET) group and the double embryo transfer (DET) group.
Results: For POSEIDON Group 1, the live birth rate per embryo transfer of the DET group was slightly higher than the eSET group (52.17% vs 46.15%, OR 0.786, 95% CI 0.462-1.337, P = 0.374; adjusted OR (aOR) 0.622, 95% CI 0.340-1.140, P = 0.124), while a significant increase of 20.00% in the multiple birth rate was shown. For Group 2, higher live birth rates were observed in the DET group compared to the eSET group (38.46% vs 20.48%, OR 0.412, 95% CI 0.190-0.892, P = 0.024; aOR 0.358, 95% CI 0.155-0.828, P = 0.016). The difference in the multiple birth rate was 20.00% without statistical significance. Univariate and multivariate analyses revealed that age (OR 0.759, 95% CI .624-0.922, P = 0.006 and OR 0.751, 95% CI 0.605-0.932, P = 0.009) and the number of transferred embryos (OR 0.412, 95% CI 0.190-0.892, P = 0.024 and OR 0.367, 95% CI 0.161-0.840, P = 0.018) were significant variables for the live birth rate in POSEIDON Group 2.
Conclusions: The findings in the present study showed that eSET was preferred in the first frozen cycle for POSEIDON Group 1 to avoid unnecessary risks. Double embryo transfer strategy could be considered to improve the success rate for POSEIDON Group 2 with caution. Further stratification by age is needed for a more scientific discussion about the embryo transfer strategy for POSEIDON patients.
Keywords: Embryo transfer strategy; Live birth rate; Low prognosis; Multiple birth rate; POSEIDON criteria.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.Hum Reprod. 2021 Jul 19;36(8):2157-2169. doi: 10.1093/humrep/deab152. Hum Reprod. 2021. PMID: 34179973 Free PMC article.
-
The role of age and AMH on cumulative live birth rates over multiple frozen-thawed embryo transfer cycles: a study based on low prognosis patients of POSEIDON 3 and 4 groups.Reprod Biol Endocrinol. 2024 Jun 17;22(1):69. doi: 10.1186/s12958-024-01243-5. Reprod Biol Endocrinol. 2024. PMID: 38886751 Free PMC article.
-
Elective single embryo transfer following in vitro fertilization.J Obstet Gynaecol Can. 2010 Apr;32(4):363-377. doi: 10.1016/S1701-2163(16)34482-6. J Obstet Gynaecol Can. 2010. PMID: 20500945
-
Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.Hum Reprod. 2019 Mar 1;34(3):491-505. doi: 10.1093/humrep/dey388. Hum Reprod. 2019. PMID: 30689865
-
Immediate versus postponed frozen embryo transfer after IVF/ICSI: a systematic review and meta-analysis.Hum Reprod Update. 2021 Jun 22;27(4):623-642. doi: 10.1093/humupd/dmab002. Hum Reprod Update. 2021. PMID: 33594441
Cited by
-
How to balance the live birth rate and the multiple pregnancy rate by selecting the cleavage-stage embryo number and quality for POSEIDON Group 1 and Group 2? A retrospective study.Arch Gynecol Obstet. 2025 Feb;311(2):507-517. doi: 10.1007/s00404-024-07850-2. Epub 2024 Dec 16. Arch Gynecol Obstet. 2025. PMID: 39680145 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources